Steady progress towards delivering on
strategic plan objectives
Q3-2023 Highlights
- Revenues increased 19.2% to $130.8
million, compared to $109.7
million for the same quarter last year.
- Gross margin increased 38.8% to $39.2
million, compared to $28.3
million for the same quarter last year.
- Gross margin as a percentage of revenues(1) was
30.0%, compared to 25.8% for the same quarter last year. On a
sequential basis, gross margin as a percentage of revenues
increased from 29.3% for the second quarter of this year.
- Adjusted EBITDA(2) increased 122.0% to $10.0 million, or 7.7% of revenues(2),
compared to $4.5 million, or 4.1% of
revenues, for the same quarter last year.
- Net loss was $5.5 million, or
$0.06 per share, compared to a net
loss of $3.5 million, or $0.04 per share, for the same quarter last
year.
- Cash flow from operating activities and changes in non-cash
working capital items, in the third quarter, contributed to a
notable sequential long-term debt reduction of $36.4 million, or 21.9%, from $166.2 million as at September 30, 2022 to $129.8 million as at December 31, 2022.
- Q3 bookings(1) reached $136.6 million, which translated into a
book-to-bill ratio(1) of 1.04 for the quarter, and on a
trailing twelve months basis, bookings were $508.5 million, which translated into a
book-to-bill ratio of 1.00.
- Signed 37 new clients.
MONTREAL, Feb. 14,
2023 /CNW/ - Alithya Group inc. (TSX: ALYA) (NASDAQ:
ALYA) ("Alithya" or the "Company") reported today its results for
the third quarter of fiscal 2023 ended December 31, 2022. All
amounts are in Canadian dollars unless otherwise stated.
Summary of the financial results for the third
quarter:
Financial
Highlights (in
thousands of $, except for margin percentages)
|
F2023-Q3
|
F2022-Q3
|
Revenues
|
130,780
|
109,713
|
Gross Margin
|
39,218
|
28,257
|
Gross Margin
(%)
|
30.0 %
|
25.8 %
|
Selling, general and
administrative expenses
|
31,196
|
25,002
|
Selling, general and
administrative expenses (%)(1)
|
23.9 %
|
22.8 %
|
Adjusted
EBITDA(2)
|
10,021
|
4,514
|
Adjusted EBITDA Margin
(%)(2)
|
7.7 %
|
4.1 %
|
Net loss
|
(5,505)
|
(3,486)
|
(1)
|
This earnings release
incorporates by reference section 5, "Non-IFRS and Other Financial
Measures", of Alithya's Management and Discussion and Analysis
("MD&A") for the quarter ended December 31, 2022, filed on
SEDAR at www.sedar.com and on EDGAR at www.sec.gov, which
includes explanations of the composition and usefulness of these
other financial measures.
|
(2)
|
These are non-IFRS
financial measures or ratios without a standardized definition
under IFRS, which may not be comparable to similar measures or
ratios used by other issuers. Definition and quantitative
reconciliation of Adjusted EBITDA to the most directly comparable
IFRS measure is presented below under the caption "Non-IFRS and
other financial measures". "Adjusted EBITDA Margin" refers to the
percentage of total revenue that Adjusted EBITDA represents for a
given period. This earnings release incorporates by reference
section 5, "Non-IFRS and Other Financial Measures", of
Alithya's MD&A for the quarter ended December 31, 2022, filed
on SEDAR at www.sedar.com and on EDGAR at www.sec.gov, which
includes explanations of the composition and usefulness of these
non-IFRS financial measures and non-IFRS ratios.
|
Quote by Paul Raymond,
President and CEO, Alithya:
"I am very proud of our team's Q3 performance. Despite global
uncertainties, we delivered quarterly improvements on many
important fronts. Strong year-over-year revenue growth, improving
gross margins and EBITDA, and significant cash generation and debt
reduction, are the result of the continued deployment of our
strategic plan. As we move forward in the final quarter of our 2023
fiscal year, and look ahead to fiscal 2024, we remain focused on
delivering on our long term objectives, while further leveraging
our expertise and reputation as a trusted advisor."
Third Quarter Results
Revenues
Revenues amounted to $130.8
million for the three months ended
December 31, 2022, including $12.6
million from Vitalyst, LLC ("Vitalyst") and Datum Consulting
Group, LLC and its affiliates ("Datum"), following their
acquisitions by the Company on January 31, 2022 and
July 1, 2022 (the "Datum Acquisition"), respectively,
representing a $21.1 million
increase, or 19.2%, from $109.7
million for the three months ended
December 31, 2021. On a sequential basis, revenues also
increased by $1.9 million, from
$128.9 million for the second
quarter of this year.
Revenues in Canada increased by
$4.4 million, or 6.0%, to
$77.5 million for the three months
ended December 31, 2022, from $73.1 million for the three months ended
December 31, 2021. The increase in revenues was due to
organic growth in all areas, including growth from the two
long-term contracts signed as part of an acquisition in the first
quarter of last year.
U.S. revenues increased by $15.8
million, or 47.9%, to $48.9
million for the three months ended
December 31, 2022, from $33.1
million for the three months ended
December 31, 2021, due to revenues of $12.6 million from the acquisitions of Vitalyst
and Datum, and a favorable US$ exchange rate impact of $3.5 million.
International revenues increased by $0.9
million, or 24.6%, to $4.4
million for the three months ended
December 31, 2022, from $3.5
million for the three months ended
December 31, 2021, driven by organic growth in activity
levels, partially offset by an unfavorable foreign exchange rate
impact of $0.2 million between the
two periods.
Gross Margin
Gross margin increased by $10.9
million, or 38.8%, to $39.2
million for the three months ended
December 31, 2022, from $28.3
million for the three months ended
December 31, 2021. Gross margin as a percentage of
revenues increased to 30.0% for the three months ended
December 31, 2022, from 25.8% for the three months ended
December 31, 2021. On a sequential basis, gross margin as
a percentage of revenues increased from 29.3% for the second
quarter of this year.
In Canada, gross margin as a
percentage of revenues increased, compared to the same quarter last
year, due to increased revenues from permanent employees relative
to subcontractors, higher average revenue per employee, and higher
margin offerings. Gross margin as a percentage of revenues also
increased on a sequential basis, mainly due to higher average
revenue per employee and higher margin offerings, compared to the
second quarter of this year.
In the U.S., gross margin as a percentage of revenues increased,
compared to the same quarter last year, as a result of a positive
margin impact from the acquisitions of Vitalyst and Datum, higher
average revenue per employee, and improved project performance in
other areas of the business. Gross margin as a percentage of
revenues also increased on a sequential basis, mainly due to higher
average revenue per employee and improved project performance in
certain areas of the business, compared to the second quarter of
this year.
International gross margin as a percentage of revenues decreased
compared to the same quarter last year, mainly as a result of
inflationary pressures on salary costs and more non-billable
hours.
Selling, General and Administrative Expenses
Selling, general and administrative expenses totaled $31.2
million for the three months ended December 31, 2022, an
increase of $6.2 million, or 24.8%,
from $25.0 million for the three months ended
December 31, 2021. Selling, general and administrative
expenses, as a percentage of revenues, amounted to 23.9% for the
three months ended December 31, 2022, compared to 22.8%
for the same period last year, driven mostly by the higher
historical selling, general and administrative expense percentage
of Vitalyst and an unfavorable US$ exchange rate impact of
$1.0 million, partially offset by
reductions in other expense categories. On a sequential basis,
expenses increased by $0.8 million, from $30.4 million for the second quarter, driven
by an unfavorable US$ exchange rate impact of $0.5 million and sequential increases in certain
discretionary spending categories such as travel, business
development, and information technology and communications costs,
partially offset by reductions in other expense categories.
Adjusted EBITDA
Adjusted EBITDA amounted to $10.0
million for the three months ended
December 31, 2022, representing an increase of
$5.5 million, or 122.0%, from
$4.5 million for the three months
ended December 31, 2021. As explained above, increased
gross margin and the contributions from the acquisitions of
Vitalyst and Datum were partially offset by increased selling,
general and administrative expenses. Adjusted EBITDA Margin was
7.7% for the three months ended December 31, 2022,
compared to 4.1% for the three months ended
December 31, 2021.
Net Loss
Net loss for the three months ended December 31, 2022
was $5.5 million, an increase of
$2.0 million, from $3.5 million for the three months ended
December 31, 2021. The increased loss was driven mainly
by increased business acquisition, integration and reorganization
costs and increased depreciation and amortization of intangibles,
as a result of the Datum Acquisition, as well as increased selling,
general and administrative expenses, increased net financial
expenses, and increased income tax expense, partially offset by
increased gross margin in the three months ended
December 31, 2022, compared to the three months ended
December 31, 2021. On a per share basis, this translated
into a basic and diluted net loss per share of $0.06 for the three months ended
December 31, 2022, compared to a net loss of $0.04 per share for the three months ended
December 31, 2021.
Liquidity and Capital Resources
For the three months ended December 31, 2022, net cash
from operating activities was $34.9 million, representing an
increase of $23.8 million,
or 215.8%, from $11.1 million
for the three months ended December 31, 2021. The cash
flows for the three months ended December 31, 2022
resulted primarily from the net loss of $5.5 million,
plus $14.3 million of non-cash
adjustments to the net loss, consisting primarily of depreciation
and amortization, net financial expenses, share-based compensation,
foreign exchange loss on repayment of long-term debt, deferred
taxes, and unrealized foreign exchange, and $26.1 million in favorable changes in
non-cash working capital items. In comparison, the cash flows for
the three months ended December 31, 2021 resulted
primarily from the net loss of $3.5 million, plus $6.7 million of non-cash adjustments to the
net loss, consisting primarily of depreciation and amortization,
net financial expenses, and share-based compensation, and
$7.8 million in favorable
changes in non-cash working capital items.
Nine-Month Results
Revenues amounted to $386.5
million for the nine months ended
December 31, 2022, including $34.2
million from the acquisitions of Vitalyst and Datum,
representing a $68.6 million
increase, or 21.6%, from $317.9
million last year. Gross margin increased by $25.9 million, or 30.5%, to $111.0 million, from $85.1
million last year. Adjusted EBITDA amounted to $25.7 million, representing an increase of
$9.1 million, or 54.9%, from
$16.6 million, including the
forgiveness of $5.9 million in PPP
loans, last year. Net loss was $10.1
million, an increase of $1.8
million, from $8.3 million, including the forgiveness of
$5.9 million in PPP loans, last year.
On a per share basis, this translated into a basic and diluted net
loss per share of $0.11, compared to
a net loss of $0.10 per share last
year.
Outlook
Notwithstanding the ongoing global uncertainties, the Company
maintains focus on its long-term strategic plan, which sets as a
goal to consolidate its position to become a trusted leader in
digital transformation.
According to this plan, Alithya's consolidated scale and scope
should allow it to leverage its geographies, expertise, integrated
offerings, and position on the value chain to target the fastest
growing IT services segments. Alithya's specialization in digital
technologies and its flexibility to deploy enterprise solutions and
deliver solutions tailored to specific business objectives,
responds directly to client expectations. More specifically,
Alithya has established a three-pronged growth plan focusing
on:
- Increasing scale through organic growth and complementary
acquisitions;
- Achieving best-in-class employee engagement;
- Providing its investors, partners and stakeholders with
long-term growing return on investment.
Forward-Looking Statements
This press release contains statements that may constitute
"forward-looking information" within the meaning of applicable
Canadian securities laws and "forward-looking statements" within
the meaning of the U.S. Private Securities Litigation Reform Act of
1995 and other applicable U.S. safe harbours (collectively
"forward-looking statements"). Statements that do not exclusively
relate to historical facts, as well as statements relating to
management's expectations regarding the future growth, results of
operations, performance and business prospects of Alithya, and
other information related to Alithya's business strategy and future
plans or which refer to the characterizations of future events or
circumstances represent forward-looking statements. Such statements
often contain the words "anticipates," "expects," "intends,"
"plans," "predicts," "believes," "seeks," "estimates," "could,"
"would," "will," "may," "can," "continue," "potential," "should,"
"project," "target," and similar expressions and variations
thereof, although not all forward-looking statements contain these
identifying words.
Forward-looking statements in this press release include, among
other things, information or statements about: (i) our ability to
generate sufficient earnings to support our operations; (ii) our
ability to take advantage of business opportunities and meet our
goals set in our three-year strategic plan; (iii) our ability to
develop new business, broaden the scope of our service offerings
and enter into new contracts; (iv) our strategy, future operations,
and prospects; (v) our need for additional financing and our
estimates regarding our future financing and capital requirements;
(vi) our expectations regarding our financial performance,
including our revenues, profitability, research and development,
costs and expenses, gross margins, liquidity, capital resources,
and capital expenditures; (vii) our ability to realize the expected
synergies or cost savings relating to the integration of our
business acquisitions, and (viii) the potential return to
pre-COVID-19 pandemic operations.
Forward-looking statements are presented for the sole purpose of
assisting investors and others in understanding Alithya's
objectives, strategies and business outlook as well as its
anticipated operating environment and may not be appropriate for
other purposes. Although management believes the expectations
reflected in Alithya's forward-looking statements were reasonable
as at the date they were made, forward-looking statements are based
on the opinions, assumptions and estimates of management and, as
such, are subject to a variety of risks and uncertainties and other
factors, many of which are beyond Alithya's control, and which
could cause actual events or results to differ materially from
those expressed or implied in such statements. Such risks and
uncertainties include but are not limited to those discussed in the
section titled "Risks and Uncertainties" of Alithya's, Management's
Discussion and Analysis for the year ended March 31, 2022,
Management's Discussion and Analysis for the quarter ended
June 30, 2022 and Management's
Discussion and Analysis for the quarter ended December 31,
2022, as well as in Alithya's other materials made public,
including documents filed with Canadian and U.S. securities
regulatory authorities from time to time and which are available on
SEDAR at www.sedar.com and EDGAR at www.sec.gov. Additional
risks and uncertainties not currently known to Alithya or that
Alithya currently deems to be immaterial could also have a material
adverse effect on its financial position, financial performance,
cash flows, business or reputation.
Forward-looking statements contained in this press release are
qualified by these cautionary statements and are made only as of
the date of this press release. Alithya expressly disclaims any
obligation to update or alter any forward-looking statements, or
the factors or assumptions underlying them, whether as a result of
new information, future events or otherwise, except as required by
applicable law. Investors are cautioned not to place undue reliance
on forward-looking statements since actual results may vary
materially from them.
Non-IFRS Measures and other financial Measures
This press release includes certain measures which have not been
prepared in accordance with IFRS and other financial measures.
EBITDA, EBITDA Margin, Adjusted EBITDA and Adjusted EBITDA Margin
are non-IFRS measures and Bookings, Book-to-Bill Ratio, Gross
Margin as a Percentage of Revenues and Selling, General and
Administrative Expenses as a Percentage of Revenues are other
financial measures used in this press release. These measures do
not have any standardized meaning prescribed by IFRS and are
therefore unlikely to be comparable to similar measures presented
by other companies. These measures should be considered as
supplemental in nature and not as a substitute for the related
financial information prepared in accordance with IFRS. Additional
details for these non-IFRS and other financial measures can be
found in section 5, "Non-IFRS and Other Financial Measures",
of Alithya's MD&A for the quarter ended December 31, 2022, filed on SEDAR at
www.sedar.com and on EDGAR at www.sec.gov, and are incorporated by
reference in this press release, which includes explanations of the
composition and usefulness of these non-IFRS financial measures and
non-IFRS ratios.
The following table reconciles net loss to EBITDA and Adjusted
EBITDA:
|
|
For the three months
ended
December
31,
|
|
For the nine months
ended
December
31,
|
(in $
thousands)
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
|
|
$
|
|
$
|
|
$
|
|
$
|
Revenues
|
|
130,780
|
|
109,713
|
|
386,477
|
|
317,911
|
Net
loss
|
|
(5,505)
|
|
(3,486)
|
|
(10,104)
|
|
(8,295)
|
Net financial
expenses
|
|
2,664
|
|
1,203
|
|
6,758
|
|
3,227
|
Income tax expense
(recovery)
|
|
379
|
|
(130)
|
|
(5,751)
|
|
(2,452)
|
Depreciation
|
|
1,634
|
|
1,400
|
|
4,815
|
|
4,200
|
Amortization of
intangibles
|
|
7,397
|
|
3,438
|
|
18,804
|
|
10,268
|
EBITDA
(1)
|
|
6,569
|
|
2,425
|
|
14,522
|
|
6,948
|
EBITDA Margin
(1)
|
|
5.0 %
|
|
2.2 %
|
|
3.8 %
|
|
2.2 %
|
Adjusted
for:
|
|
|
|
|
|
|
|
|
Foreign exchange loss
(gain)
|
|
163
|
|
(27)
|
|
63
|
|
(1)
|
Share-based
compensation
|
|
1,999
|
|
1,139
|
|
5,161
|
|
3,517
|
Business acquisition,
integration and
reorganization costs
|
|
1,290
|
|
857
|
|
5,913
|
|
5,489
|
Internal ERP systems
implementation
|
|
—
|
|
120
|
|
—
|
|
608
|
Adjusted EBITDA
(1)
|
|
10,021
|
|
4,514
|
|
25,659
|
|
16,561
|
Adjusted EBITDA Margin
(1)
|
|
7.7 %
|
|
4.1 %
|
|
6.6 %
|
|
5.2 %
|
|
|
|
|
|
|
|
|
|
(1) Non-IFRS measure. See section 5
titled "Non-IFRS and Other Financial Measures" of Alithya's
MD&A for the quarter ended December 31, 2022, filed on SEDAR at
www.sedar.com and on EDGAR at www.sec.gov.
|
Conference Call
Alithya will hold a conference call to discuss these results on
February 14, 2023, at 9:00 AM Eastern Time. Interested parties can join
the call by dialing 1 (888) 396 8049 or (416) 764 8646, conference
ID: 66704459, or via webcast at https://www.icastpro.ca/oermy4. The
conference call recording can be accessed via Alithya's website
under the Investors section, or directly at
https://www.alithya.com/en/investors.
About Alithya
Alithya is a trusted North American leader in strategy and
digital transformation, employing a dedicated and highly skilled
workforce of 3,700 professionals in Canada, the United
States and internationally. Since its founding in 1992,
Alithya's capacity, size, and capabilities have continuously
evolved, guided by a long-term strategic vision to become the
trusted advisor of its clients. Alithya's strategy is based on a
plan of accelerated organic growth and complementary acquisitions
to create a global leader.
The company's integrated offer is based on four pillars of
expertise: business strategies, enterprise cloud solutions,
application services, and data and analytics. Alithya deploys
leading-edge solutions, services, and skills as one of the most
prominent consulting firms, driving successful digital change as a
trusted advisor to customers in a variety of sectors, including
financial services, insurance, manufacturing, renewable
energy, telecommunications, transport and logistics, professional
services, healthcare, government, and beyond. Alithya strives to be
a model of corporate responsibility, professional equity,
diversity, and inclusion, with a vibrant business culture that
embraces social consciousness at its core. To learn more about
Alithya, visit www.alithya.com.
Note to readers: Management's Discussion and Analysis and
the interim consolidated financial statements and notes for the
three and nine months ended December 31,
2022 are available on SEDAR at www.sedar.com, on EDGAR at
www.sec.gov and on the Company's website at www.alithya.com.
Shareholders may, upon request, receive a hard copy of these
documents free of charge.
View original
content:https://www.prnewswire.com/news-releases/alithya-reports-third-quarter-continued-growth-and-improved-performance-301746070.html
SOURCE Alithya